Katherine Chenevey
Family Medicine · Washington Court House, OHNPI 1205497716
Payments from drug & device makers
Across 71 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$216
- Novo Nordisk$192
- Bayer$111
- AstraZeneca$104
- Pfizer$104
- Lilly USA, LLC$76
- plus $547 from 19 others
What the payments were for
- Food & beverage$1,350100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $216 |
| Novo Nordisk | 9 | $192 |
| Bayer | 6 | $111 |
| AstraZeneca | 6 | $104 |
| Pfizer | 6 | $104 |
| Lilly USA, LLC | 5 | $76 |
| Astellas Pharma US Inc | 3 | $61 |
| Abbott | 3 | $54 |
| Dexcom, Inc. | 2 | $43 |
| Boehringer Ingelheim | 2 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Merck | 2 | $35 |
| Dynavax Technologies Corporation | 2 | $34 |
| Acadia Pharmaceuticals Inc | 1 | $32 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Exact Sciences | 1 | $25 |
| Krystal Biotech Inc | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| GSK | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Cranial Technologies, Inc | 1 | $16 |
| Novartis | 1 | $14 |
| Kaleo, Inc. | 1 | $12 |
How this compares
$1,350 in reported general payments places this provider in the 65th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 147 | $142,231 |
| OzempicSemaglutide | 57 | $69,983 |
| JardianceEmpagliflozin | 49 | $60,744 |
| TrulicityDulaglutide | 36 | $47,806 |
| FarxigaDapagliflozin Propanediol | 43 | $46,144 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $41,111 |
| MounjaroTirzepatide | 17 | $20,271 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 26 | $13,613 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 69 | $13,479 |
| XareltoRivaroxaban | 14 | $13,029 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $12,530 |
| JanuviaSitagliptin Phosphate | 12 | $10,651 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $9,181 |
| SymbicortBudesonide/Formoterol Fumarate | 24 | $7,771 |
| Atorvastatin Calcium | 473 | $5,421 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $104 | $142,231147 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $38 | $74,35675 claims |
| Novo NordiskOzempic | $192 | $69,98357 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $76 | $68,07653 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $104 | $66,44579 claims |
| GSKTrelegy Ellipta | $17 | $41,11136 claims |
| MerckJanuvia | $35 | $10,65112 claims |
| AbbVieSynthroid | $216 | $1,33815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Washington Court House
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.